2. Academic Validation
  3. A small-molecule fusion inhibitor of influenza virus is orally active in mice

A small-molecule fusion inhibitor of influenza virus is orally active in mice

  • Science. 2019 Mar 8;363(6431):eaar6221. doi: 10.1126/science.aar6221.
Maria J P van Dongen  # 1 2,  Rameshwar U Kadam  # 3,  Jarek Juraszek 4,  Edward Lawson 5,  Boerries Brandenburg 4 6,  Frederike Schmitz 4,  Wim B G Schepens 2,  Bart Stoops 2,  Harry A van Diepen 4,  Mandy Jongeneelen 4 6,  Chan Tang 4 6,  Jan Vermond 4,  Alida van Eijgen-Obregoso Real 4,  Sven Blokland 4 6,  Divita Garg 7,  Wenli Yu 3,  Wouter Goutier 4,  Ellen Lanckacker 8,  Jaco M Klap 4,  Daniëlle C G Peeters 2,  Jin Wu 8,  Christophe Buyck 2,  Tim H M Jonckers 8,  Dirk Roymans 8,  Peter Roevens 2,  Ronald Vogels 4 6,  Wouter Koudstaal 4,  Robert H E Friesen 4,  Pierre Raboisson 8,  Dashyant Dhanak 2 5,  Jaap Goudsmit 4 9,  Ian A Wilson 10 11
Affiliations

Affiliations

  • 1 Janssen Prevention Center, Janssen Pharmaceutical Companies of Johnson & Johnson, Archimedesweg 6, Leiden, Netherlands. mvandon@its.jnj.com wilson@scripps.edu.
  • 2 Discovery Sciences, Janssen Research & Development, Turnhoutseweg 30, Beerse, Belgium.
  • 3 Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • 4 Janssen Prevention Center, Janssen Pharmaceutical Companies of Johnson & Johnson, Archimedesweg 6, Leiden, Netherlands.
  • 5 Discovery Sciences, Janssen Research & Development, 1400 McKean Rd., Spring House, PA, USA.
  • 6 Janssen Infectious Diseases and Vaccines, Janssen Research & Development, Archimedesweg 4-6, Leiden, Netherlands.
  • 7 Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
  • 8 Janssen Infectious Diseases and Vaccines, Janssen Research & Discovery, Turnhoutseweg 30, Beerse, Belgium.
  • 9 Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • 10 Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA. mvandon@its.jnj.com wilson@scripps.edu.
  • 11 The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA, USA.
  • # Contributed equally.
PMID: 30846569 DOI: 10.1126/science.aar6221
Abstract

Recent characterization of broadly neutralizing Antibodies (bnAbs) against Influenza Virus identified the conserved hemagglutinin (HA) stem as a target for development of universal vaccines and therapeutics. Although several stem bnAbs are being evaluated in clinical trials, Antibodies are generally unsuited for oral delivery. Guided by structural knowledge of the interactions and mechanism of anti-stem bnAb CR6261, we selected and optimized small molecules that mimic the bnAb functionality. Our lead compound neutralizes influenza A group 1 viruses by inhibiting HA-mediated fusion in vitro, protects mice against lethal and sublethal influenza challenge after oral administration, and effectively neutralizes virus Infection in reconstituted three-dimensional Cell Culture of fully differentiated human bronchial epithelial cells. Cocrystal structures with H1 and H5 HAs reveal that the lead compound recapitulates the bnAb hotspot interactions.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z